HCWB: HCW Biologics Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 15.59
Enterprise Value ($M) 33.73
Book Value ($M) -9.97
Book Value / Share -0.22
Price / Book -1.56
NCAV ($M) -34.43
NCAV / Share -0.77
Price / NCAV -0.45

Profitability (mra)
Return on Invested Capital (ROIC) -4.07
Return on Assets (ROA) -1.31
Return on Equity (ROE) -2.77

Liquidity (mrq)
Quick Ratio 0.09
Current Ratio 0.09

Balance Sheet (mrq) ($M)
Current Assets 2.09
Assets 26.56
Liabilities 36.53
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
11-22 13D/A Wong Hing C 36.04

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-05-15 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1)
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-04-01 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-22 12,802 88,396 14.48
2025-01-21 24,797 112,305 22.08
2025-01-17 5,925 89,637 6.61

(click for more detail)

Similar Companies
FULC – Fulcrum Therapeutics, Inc. GANX – Gain Therapeutics, Inc.
GHRS – GH Research PLC HRMY – Harmony Biosciences Holdings, Inc.
HROW – Harrow, Inc.


Financial data and stock pages provided by
Fintel.io